Dogwood Therapeutics, Inc. SEC filings DWTX
Dogwood Therapeutics, Inc. has 329 filings in SEC EDGAR's recent list, going back to Jul 24, 2020. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jan 29, 2026 | — |
| CORRESP | Letter to the SEC | Jan 27, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 27, 2026 | — |
| EFFECT | Filing | Jun 2, 2025 | — |
| CORRESP | Letter to the SEC | May 29, 2025 | — |
| UPLOAD | Letter from the SEC | May 28, 2025 | — |
| EFFECT | Filing | Apr 28, 2022 | — |
| CORRESP | Letter to the SEC | Apr 26, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 23, 2022 | — |
| EFFECT | Filing | Dec 16, 2020 | — |
| CERT | Filing | Dec 16, 2020 | — |
| 8-A12B | Filing | Dec 16, 2020 | — |
| CORRESP | Letter to the SEC | Dec 14, 2020 | — |
| CORRESP | Letter to the SEC | Dec 14, 2020 | — |
| CORRESP | Letter to the SEC | Dec 1, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 30, 2020 | — |
| CORRESP | Letter to the SEC | Oct 23, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 21, 2020 | — |
| CORRESP | Letter to the SEC | Oct 2, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 1, 2020 | — |
| CORRESP | Letter to the SEC | Sep 25, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2020 | — |
| CORRESP | Letter to the SEC | Sep 15, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2020 | — |
| CORRESP | Letter to the SEC | Aug 27, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 20, 2020 | — |
| DRSLTR | Filing | Jul 24, 2020 | — |
| DRS | Filing | Jul 24, 2020 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DWTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Alpharetta, GA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1818844
- Former names
- Virios Therapeutics, Inc. (until Oct 15, 2024); Virios Therapeutics, LLC (until Dec 16, 2020)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.